H-L-Asp(Bzl)-OBzl*HCl

H-L-Asp(Bzl)-OBzl*HCl is a benzyl-protected aspartic acid derivative in which the side-chain carboxyl group is masked as a benzyl ester (Asp(Bzl)) and the α-carboxyl group is present as a benzyl ester (OBzl), with the amine maintained in the free L-amino acid form under hydrochloride salt conditions. The molecule therefore contains an L-configured stereocenter at the α-carbon, a benzylated side-chain ester that can be selectively removed to regenerate the acidic functionality, and an N-H that participates in peptide coupling chemistry after appropriate activation. Ester-protected carboxyl groups reduce polarity and suppress undesired side reactions during acylation steps, while the benzyl groups provide a robust protecting-group strategy compatible with common peptide synthesis workflows. The hydrochloride salt form improves handling of the amino functionality and can influence solubility and coupling behavior in synthetic and process settings.

1. Protected Peptide Coupling

H-L-Asp(Bzl)-OBzl*HCl is used in peptide synthesis as a benzyl-protected aspartate building block where both the α-carboxyl and side-chain carboxyl are esterified to prevent intramolecular cyclization and side-chain acylation during coupling. The L-configuration at the α-carbon supports stereochemically consistent incorporation into peptide chains, while the free amino group under HCl salt conditions can be converted into a reactive nucleophile for standard amide bond formation. Benzyl ester protection enables sequential deprotection strategies, allowing the regenerated aspartate side-chain to participate in later steps such as salt formation, further derivatization, or coupling to additional residues. Downstream peptide analogs prepared from this intermediate can be used for backbone and side-chain chemistry studies in peptide science and for manufacturing routes that require protected, isolable amino acid derivatives.

2. Side-Chain Functionalization

H-L-Asp(Bzl)-OBzl*HCl supports side-chain functionalization workflows where the Asp(Bzl) benzyl ester acts as a protected handle for converting the side-chain carboxyl into reactive or recognition-capable motifs after deprotection. The presence of two benzyl ester groups allows controlled unveiling of carboxyl functionality, enabling downstream transformations such as formation of free carboxylic acids for metal binding studies, activation for amide/ester exchange, or incorporation into conjugation-ready derivatives. The stereodefined L-aspartate scaffold can be maintained through deprotection and subsequent coupling steps, which is important for structure-function investigations where stereochemistry governs conformational preferences. The resulting functionalized aspartate derivatives can be applied to chemical biology probes, peptidomimetic scaffolds, and intermediate preparation for larger molecular assemblies.

3. Peptidomimetic Scaffold Building

H-L-Asp(Bzl)-OBzl*HCl serves as an amino acid-based intermediate for peptidomimetic construction in synthetic organic chemistry, leveraging the aspartate side-chain carboxyl geometry and the protected ester pattern to control reactivity during scaffold assembly. The benzyl-protected carboxyl groups can be used to orchestrate stepwise formation of amide linkages or to enable late-stage unveiling of acidic functionality for incorporation into constrained analogs. The L-configuration and the preserved side-chain carbonyl orientation can be used to generate libraries of aspartate-containing fragments for molecular design efforts targeting defined hydrogen-bonding and electrostatic features. Peptidomimetic intermediates derived from this compound can feed into SAR studies, fragment-based design campaigns, and downstream synthesis of complex, carboxylate-bearing molecular frameworks.

4. Chemical Biology Labeling

H-L-Asp(Bzl)-OBzl*HCl can be employed in chemical biology labeling strategies where protected aspartate functionality is required to withstand coupling conditions while maintaining a defined acidic side chain for later conjugation. The benzyl ester protection pattern reduces the likelihood of premature carboxyl activation, enabling controlled deprotection to generate carboxylic acid sites suitable for subsequent derivatization into linkers, handles for bioconjugation, or attachment points for affinity reagents. The amine functionality under HCl salt form supports incorporation into peptide-like constructs that can be processed into labeling reagents or used to generate defined biomolecule-modifying intermediates. Downstream products can be used to prepare aspartate-containing probes for studying molecular recognition, protein-ligand interactions, and sequence-dependent chemical behavior.

5. Pharmaceutical Intermediate Preparation

H-L-Asp(Bzl)-OBzl*HCl is relevant to pharmaceutical intermediate preparation and process chemistry for producing protected aspartate derivatives that can be carried through multi-step syntheses with minimized side reactions. The dual benzyl ester protection strategy supports isolation and handling of a chiral amino acid intermediate with suppressed carboxylate reactivity during activation, coupling, and purification operations. The hydrochloride salt form can improve reproducibility of amine handling in manufacturing-scale workflows where consistent salt behavior and solubility profiles matter for downstream transformations. Deprotected aspartate-containing intermediates obtained from this material can serve as inputs for generating carboxylate-bearing fragments used in peptide-like drug candidates, enzyme-binding motifs, and other fine chemical syntheses that require stereodefined acidic functionality.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis